Clinical Trial Update: SVT-40776 in Patients Suffering From Overactive Bladder Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of SVT-40776 for overactive bladder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• SVT-40776 (SVT-40776)

Snippet

Sponsor: Salvat | Conditions: Overactive Bladder (OAB) | Phase 2 | Status: COMPLETED